Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2000 of 3546 entries
View as:

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

Phase: N/A Priority: Normal
NCT ID: NCT01446224 Org: User:
Start: 12/31/10 End: 12/31/13 Due: 12/31/14

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01702467 Org: User:
Start: 10/19/12 End: 05/15/13 Due: 05/15/14

Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone

Phase: N/A Priority: Normal
NCT ID: NCT02380313 Org: User:
Start: 10/31/15 End: 05/31/17 Due: 05/31/18

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00685750 Org: User:
Start: 04/28/08 End: 12/17/13 Due: 12/17/14

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00197080 Org: User:
Start: 06/30/05 End: 01/31/06 Due: 01/31/07

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Phase: N/A Priority: Normal
NCT ID: NCT00129116 Org: User:
Start: 03/01/03 End: 12/16/03 Due: 12/16/04

AUGMENTIN 1gm In Skin And Soft Tissue Infection

Phase: N/A Priority: Normal
NCT ID: NCT00343135 Org: User:
Start: 12/31/04 End: 03/31/05 Due: 03/31/06

A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02731846 Org: User:
Start: 06/30/16 End: 11/30/16 Due: 11/30/17

Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India

Phase: N/A Priority: Normal
NCT ID: NCT04600752 Org: User:
Start: 05/07/22 End: 11/12/22 Due: 11/12/23

Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02641912 Org: User:
Start: 03/09/16 End: 04/15/16 Due: 04/15/17

Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV

Phase: N/A Priority: Normal
NCT ID: NCT00527826 Org: User:
Start: 11/30/07 End: 07/31/09 Due: 07/31/10

A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies

Phase: N/A Priority: Normal
NCT ID: NCT01793870 Org: User:
Start: 01/15/13 End: 06/17/13 Due: 06/17/14

Sexual Functioning Study With Antidepressants

Phase: N/A Priority: Normal
NCT ID: NCT00316160 Org: User:
Start: 09/30/04 End: 05/31/05 Due: 05/31/06

Seasonal Allergic Rhinitis In Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00107757 Org: User:
Start: 03/31/05 End: 11/30/05 Due: 11/30/06

A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT04923347 Org: User:
Start: 06/06/23 End: 03/14/24 Due: 03/14/25

Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients

Phase: N/A Priority: Normal
NCT ID: NCT01602562 Org: User:
Start: 05/07/12 End: 05/24/13 Due: 05/24/14

Effects of Repeat Dosing of GSK1521498

Phase: N/A Priority: Normal
NCT ID: NCT00976105 Org: User:
Start: 09/22/09 End: 03/09/10 Due: 03/09/11

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.

Phase: N/A Priority: Normal
NCT ID: NCT02075541 Org: User:
Start: 07/08/14 End: 04/19/17 Due: 04/19/18

Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT01192165 Org: User:
Start: 09/14/10 End: 10/07/13 Due: 10/07/14

A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00731822 Org: User:
Start: 08/31/08 End: 02/28/09 Due: 02/28/10

Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT00224484 Org: User:
Start: 04/07/04 End: 07/24/07 Due: 07/24/08

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

Phase: N/A Priority: Normal
NCT ID: NCT00697216 Org: User:
Start: 03/31/97 End: - Due: -

The CLEVER Study - Coreg And Left Ventricular Mass Regression

Phase: N/A Priority: Normal
NCT ID: NCT00108082 Org: User:
Start: 01/31/05 End: 08/31/08 Due: 08/31/09

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Phase: N/A Priority: Normal
NCT ID: NCT00346892 Org: User:
Start: 11/30/01 End: - Due: -

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

Phase: N/A Priority: Normal
NCT ID: NCT00427908 Org: User:
Start: 02/07/07 End: 12/03/07 Due: 12/03/08